Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers from the Morgridge Institute for Research and Northwestern University have created an efficient way to target and repair defective genes. Read the full WisBusiness story here.
- Wisconsin State Journal: Blexx, a startup whose tool destroys used hypodermic needles, wins Madison pitch contest.November 9, 2018
- WisBusiness: Elevator Pitch Olympics features life science startupsNovember 9, 2018
- Kelly Lietz on LinkedIn: Identifying Win-Win Opportunities in Startup InvestingNovember 9, 2018
- InsideWis: Tech, art and design of ‘smart’ cities converge through Wisconsin companyNovember 6, 2018
- Venture Investors director John Neis to join Tech Council’s ‘Investor Hall of Fame’November 2, 2018